Impact  	Impact  	 NN	O
of  	of  	 IN	O
regular  	regular  	 JJ	B-NP
aspirin  	aspirin  	 JJ	I-NP
use  	use  	 NN	I-NP
on  	on  	 IN	O
overall  	overall  	 JJ	O
and  	and  	 CC	O
cancer-specific  	cancer-specific  	 JJ	B-NP
survival  	survival  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
colorectal  	colorectal  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
harboring  	harboring  	 VBG	O
a  	a  	 DT	O
PIK3CA  	PIK3CA  	 JJ	O
mutation  	mutation  	 JJ	O
Recent  	Recent  	 JJ	O
data  	data  	 NNS	O
have  	have  	 VBP	O
suggested  	suggested  	 VBN	O
that  	that  	 IN	O
regular  	regular  	 JJ	B-NP
aspirin  	aspirin  	 JJ	I-NP
use  	use  	 NN	I-NP
improves  	improves  	 VBZ	O
overall  	overall  	 JJ	O
and  	and  	 CC	O
cancer-specific  	cancer-specific  	 JJ	B-NP
survival  	survival  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
subset  	subset  	 NN	B-NP
of  	of  	 IN	I-NP
colorectal  	colorectal  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
CRC 	CRC 	 NNP	B-NP
)  	)  	 -RRB-	O
patients  	patients  	 FW	O
harboring  	harboring  	 FW	O
PIK3CA  	PIK3CA  	 FW	O
mutations 	mutations 	 FW	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
PIK3CA-mutated  	PIK3CA-mutated  	 NNP	O
CRC  	CRC  	 NNP	O
patients  	patients  	 NNS	O
examined  	examined  	 VBN	O
in  	in  	 IN	O
these  	these  	 DT	O
studies  	studies  	 NNS	O
was  	was  	 VBD	O
modest 	modest 	 JJ	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
collaborative  	collaborative  	 JJ	B-NP
study  	study  	 NN	I-NP
aims  	aims  	 VBZ	O
to  	to  	 TO	O
validate  	validate  	 VB	O
the  	the  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
regular  	regular  	 JJ	B-NP
aspirin  	aspirin  	 JJ	I-NP
use  	use  	 NN	I-NP
and  	and  	 CC	O
survival  	survival  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
PIK3CA-mutated  	PIK3CA-mutated  	 NNP	O
CRC 	CRC 	 NNP	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
with  	with  	 IN	O
PIK3CA-mutated  	PIK3CA-mutated  	 NNP	O
CRC  	CRC  	 NNP	O
were  	were  	 VBD	O
identified  	identified  	 VBN	O
at  	at  	 IN	O
Moffitt  	Moffitt  	 NNP	O
Cancer  	Cancer  	 NNP	O
Center  	Center  	 NNP	O
( 	( 	 -LRB-	O
MCC 	MCC 	 NNP	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
United  	United  	 NNP	B-NP
States  	States  	 NNPS	I-NP
and  	and  	 CC	O
Royal  	Royal  	 NNP	O
Melbourne  	Melbourne  	 NNP	O
Hospital  	Hospital  	 NNP	O
( 	( 	 -LRB-	O
RMH 	RMH 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
Australia 	Australia 	 NNP	B-NP
.  	.  	 .	O
Prospective  	Prospective  	 JJ	B-NP
clinicopathological  	clinicopathological  	 JJ	I-NP
data  	data  	 NNS	I-NP
and  	and  	 CC	O
survival  	survival  	 NN	B-NP
data  	data  	 NNS	I-NP
were  	were  	 VBD	O
available 	available 	 JJ	O
.  	.  	 .	O
At  	At  	 IN	O
MCC 	MCC 	 NNP	O
,  	,  	 ,	O
PIK3CA  	PIK3CA  	 CD	O
mutations  	mutations  	 NNS	O
were  	were  	 VBD	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
targeted  	targeted  	 JJ	O
exome  	exome  	 NNS	B-NP
sequencing  	sequencing  	 VBP	O
using  	using  	 VBG	O
the  	the  	 DT	O
Illumina  	Illumina  	 NNP	B-NP
GAIIx  	GAIIx  	 NNP	I-NP
Next  	Next  	 NNP	O
Generation  	Generation  	 NNP	B-NP
Sequencing  	Sequencing  	 NNP	I-NP
platform 	platform 	 NN	I-NP
.  	.  	 .	O
At  	At  	 IN	O
RMH 	RMH 	 NNP	B-NP
,  	,  	 ,	O
Sanger  	Sanger  	 NNP	B-NP
sequencing  	sequencing  	 NN	I-NP
was  	was  	 VBD	O
utilized 	utilized 	 VBN	O
.  	.  	 .	O
Multivariate  	Multivariate  	 JJ	B-NP
survival  	survival  	 NN	I-NP
analyses  	analyses  	 NNS	I-NP
were  	were  	 VBD	O
conducted  	conducted  	 VBN	O
using  	using  	 VBG	O
Cox  	Cox  	 NNP	B-NP
logistic  	logistic  	 FW	I-NP
regression 	regression 	 FW	I-NP
.  	.  	 .	O
From  	From  	 IN	O
a  	a  	 DT	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
1487  	1487  	 CD	O
CRC  	CRC  	 NN	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
185  	185  	 CD	O
patients  	patients  	 NNS	O
harbored  	harbored  	 VBP	O
a  	a  	 DT	O
PIK3CA  	PIK3CA  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Median  	Median  	 JJ	B-NP
age  	age  	 NN	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
PIK3CA-mutated  	PIK3CA-mutated  	 CD	O
tumors  	tumors  	 NNS	O
was  	was  	 VBD	O
72  	72  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
range 	range 	 NN	O
:  	:  	 :	O
34-92 	34-92 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
median  	median  	 NNS	B-NP
follow  	follow  	 VBP	O
up  	up  	 RB	O
was  	was  	 VBD	O
54  	54  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Forty-nine  	Forty-nine  	 NNP	O
( 	( 	 -LRB-	O
26 	26 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
used  	used  	 VBD	O
aspirin  	aspirin  	 VBN	O
regularly 	regularly 	 RB	O
.  	.  	 .	O
Regular  	Regular  	 JJ	B-NP
aspirin  	aspirin  	 JJ	I-NP
use  	use  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
improved  	improved  	 JJ	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	O
( 	( 	 -LRB-	O
multivariate  	multivariate  	 FW	B-NP
HR  	HR  	 FW	I-NP
0.96 	0.96 	 FW	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.86 	0.86 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
a  	a  	 DT	O
trend  	trend  	 NN	O
towards  	towards  	 IN	O
improved  	improved  	 JJ	O
cancer-specific  	cancer-specific  	 JJ	B-NP
survival  	survival  	 NN	I-NP
( 	( 	 -LRB-	O
multivariate  	multivariate  	 FW	B-NP
HR  	HR  	 NNP	I-NP
0.60 	0.60 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.14 	0.14 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
this  	this  	 DT	O
was  	was  	 VBD	O
not  	not  	 RB	O
significant 	significant 	 JJ	O
.  	.  	 .	O
Despite  	Despite  	 IN	O
examining  	examining  	 VBG	O
a  	a  	 DT	O
large  	large  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
did  	did  	 VBD	O
not  	not  	 RB	O
confirm  	confirm  	 VB	O
that  	that  	 DT	O
regular  	regular  	 JJ	B-NP
aspirin  	aspirin  	 JJ	I-NP
use  	use  	 NN	I-NP
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
statistically  	statistically  	 JJ	O
significant  	significant  	 JJ	O
improvements  	improvements  	 NNS	B-NP
in  	in  	 IN	O
survival  	survival  	 NN	O
in  	in  	 IN	O
PIK3CA-mutated  	PIK3CA-mutated  	 NNP	O
CRC  	CRC  	 NNP	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Prospective  	Prospective  	 JJ	B-NP
evaluation  	evaluation  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
relationship  	relationship  	 NN	B-NP
is  	is  	 VBZ	O
warranted 	warranted 	 VBN	O
.  	.  	 .	O
